Lysophosphatidic acid (LPA) receptors of the EDG family are differentially activated by LPA species. Structure-activity relationship of cloned LPA receptors
- PMID: 10922489
- DOI: 10.1016/s0014-5793(00)01827-5
Lysophosphatidic acid (LPA) receptors of the EDG family are differentially activated by LPA species. Structure-activity relationship of cloned LPA receptors
Abstract
We examined the structure-activity relationship of cloned lysophosphatidic acid (LPA) receptors (endothelial cell differentiation gene (EDG) 2, EDG4, and EDG7) by measuring [Ca(2+)](i) in Sf9 insect cells expressing each receptor using LPA with various acyl chains bound at either the sn-1 or the sn-2 position of the glycerol backbone. For EDG7 the highest reactivity was observed with LPA with Delta9-unsaturated fatty acid (oleic (18:1), linoleic (18:2), and linolenic (18:3)) at sn-2 followed by 2-palmitoleoyl (16:1) and 2-arachidonoyl (20:4) LPA. In contrast, EDG2 and EDG4 showed broad ligand specificities, although EDG2 and EDG4 discriminated between 14:0 (myristoyl) and 16:0 (palmitoyl), and 12:0 (lauroyl) and 14:0 LPAs, respectively. EDG7 recognizes the cis double bond at the Delta9 position of octadecanoyl residues, since 2-elaidoyl (18:1, trans) and 2-petroselinoyl (18:1, cis-Delta12) LPA were poor ligands for EDG7. In conclusion, the present study demonstrates that each LPA receptor can be activated differentially by the LPA species.
Similar articles
-
Molecular cloning and characterization of a novel human G-protein-coupled receptor, EDG7, for lysophosphatidic acid.J Biol Chem. 1999 Sep 24;274(39):27776-85. doi: 10.1074/jbc.274.39.27776. J Biol Chem. 1999. PMID: 10488122
-
Lysophosphatidic acid (LPA) receptors are activated differentially by biological fluids: possible role of LPA-binding proteins in activation of LPA receptors.FEBS Lett. 2002 Jul 17;523(1-3):187-92. doi: 10.1016/s0014-5793(02)02976-9. FEBS Lett. 2002. PMID: 12123830
-
Recombinant human G protein-coupled lysophosphatidic acid receptors mediate intracellular calcium mobilization.Mol Pharmacol. 1998 Nov;54(5):881-8. doi: 10.1124/mol.54.5.881. Mol Pharmacol. 1998. PMID: 9804623
-
Non-Edg family lysophosphatidic acid (LPA) receptors.Prostaglandins Other Lipid Mediat. 2009 Sep;89(3-4):57-65. doi: 10.1016/j.prostaglandins.2009.06.001. Epub 2009 Jun 12. Prostaglandins Other Lipid Mediat. 2009. PMID: 19524700 Review.
-
LPA(3), a unique G protein-coupled receptor for lysophosphatidic acid.Prog Lipid Res. 2010 Oct;49(4):335-42. doi: 10.1016/j.plipres.2010.03.001. Epub 2010 Mar 15. Prog Lipid Res. 2010. PMID: 20230855 Review.
Cited by
-
Integrating the puzzle pieces: the current atomistic picture of phospholipid-G protein coupled receptor interactions.Biochim Biophys Acta. 2013 Jan;1831(1):2-12. doi: 10.1016/j.bbalip.2012.09.002. Epub 2012 Sep 12. Biochim Biophys Acta. 2013. PMID: 22982815 Free PMC article. Review.
-
Synthesis and Biological Evaluation of Lysophosphatidic Acid Analogues Using Conformational Restriction and Bioisosteric Replacement Strategies.ACS Omega. 2023 Dec 11;8(51):49278-49288. doi: 10.1021/acsomega.3c07668. eCollection 2023 Dec 26. ACS Omega. 2023. PMID: 38162765 Free PMC article.
-
Pharmacological tools for lysophospholipid GPCRs: development of agonists and antagonists for LPA and S1P receptors.Acta Pharmacol Sin. 2010 Sep;31(9):1213-22. doi: 10.1038/aps.2010.135. Epub 2010 Aug 23. Acta Pharmacol Sin. 2010. PMID: 20729877 Free PMC article. Review.
-
The role of lysophosphatidic acid receptors in phenotypic modulation of vascular smooth muscle cells.Mol Biol Rep. 2010 Jul;37(6):2675-86. doi: 10.1007/s11033-009-9798-6. Epub 2009 Sep 16. Mol Biol Rep. 2010. PMID: 19757175
-
Autotaxin-Lysophosphatidic Acid: From Inflammation to Cancer Development.Mediators Inflamm. 2017;2017:9173090. doi: 10.1155/2017/9173090. Epub 2017 Dec 21. Mediators Inflamm. 2017. PMID: 29430083 Free PMC article. Review.
MeSH terms
Substances
Associated data
- Actions
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Miscellaneous